x
Help Us Guide You Better
best online ias coaching in india

2020-03-22

Download Pdf


www.thehindu.com

Relevant for: Developmental Issues | Topic: Health & Sanitation and related issues

The scheme is expected to reduce the manufacturing cost of bulk drugs. File (Representational image)   | Photo Credit: AP

The Union Cabinet has approved a scheme for promotion of bulk drug parks with a financial assistance of ₹3,000 crore for the next five years.

It has also approved a Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical drug intermediates and active pharmaceutical ingredient (API) with a financial assistance of ₹6,940 crore for the next eight years, a release issued by the Central government on Saturday said.

Also Read |

ICRA revises outlook on Indian pharma industry to ‘negative’

Time for pharma course correction

An urgent prescription

“Government will give grants-in-aid to States with a maximum limit of ₹1,000 crore per bulk drug park, which will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc.,” noted the release.

The bulk drugs parks scheme is expected to reduce the manufacturing cost of bulk drugs in the country and dependency on other countries for such as drugs.

“The Production Linked Incentive Scheme will lead to expected incremental sales of ₹46,400 crore and significant additional employment generation over 8 years,’’ noted the release.

The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, India is significantly dependent on import of basic raw materials, viz., bulk drugs that are used to produce medicines. In some specific bulk drugs, the import dependence is 80 to 100%.

“Continuous supply of drugs is necessary to ensure delivery of affordable healthcare to the citizens. Any disruption in supplies can have significant adverse impact on drug security, which is also linked to the overall economy of the country. Self-sufficiency in manufacturing of bulk drugs is highly required,” the release said.

You have reached your limit for free articles this month.

Register to The Hindu for free and get unlimited access for 30 days.

Already have an account ? Sign in

Sign up for a 30-day free trial. Sign Up

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Why you should pay for quality journalism - Click to know more

Please enter a valid email address.

Subscribe to The Hindu now and get unlimited access.

Already have an account? Sign In

Sign up for a 30-day free trial. Sign Up

To continue enjoying The Hindu, You can turn off your ad blocker or Subscribe to The Hindu.

END
© Zuccess App by crackIAS.com